| 2000 |
Chesnut CH, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, Moniz C, Peacock M, Richardson P, Watts N, Baylink D; PROOF Study Group. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med. September 2000;109(4):267-276. |
30 |
21 |
| 2003 |
Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB; Women's Health Initiative Investigators. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative Randomized Trial. JAMA. June 4, 2003;289(13):1729-1738. |
24 |
17 |
| 2011 |
Khosla S, Bellido TM, Drezner MK, Gordon CM, Harris TB, Kiel DP, Kream BE, LeBoff MS, Lian JB, Peterson CA, Rosen CJ, Williams JP, Winer KK, Sherman SS. Forum on aging and skeletal health: summary of the proceedings of an ASBMR workshop. J Bone Miner Res. November 2011;26(11):2565-2578. |
1 |
1 |
| 2020 |
LeBoff MS, Chou SH, Murata EM, Donlon CM, Cook NR, Mora S, Lee I, Kotler G, Bubes V, Buring JE, Manson JE. Effects of supplemental vitamin D on bone health outcomes in women and men in the VITamin D and OmegA‐3 TriaL (VITAL). J Bone Miner Res. May 2020;35(5):883-893. |
3 |
2 |
| 2023 |
Bouillon R, LeBoff MS, Neale RE. Health effects of vitamin D supplementation: lessons learned from randomized controlled trials and mendelian randomization studies. J Bone Miner Res. October 2023;38(10):1391-1403. |
0 |
0 |
| 2014 |
Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. October 2014;25(10):2359-2381. |
107 |
99 |
| 2021 |
Watts NB, Dore RK, Baim S, Mitlak B, Hattersley G, Wang Y, Rozental TD, LeBoff MS. Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial. Osteoporos Int. January 2021;32(1):55-61. |
0 |
0 |